CH-223191
Suppliers
Names
[ CAS No. ]:
301326-22-7
[ Name ]:
CH-223191
[Synonym ]:
2-Methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide
UNII-HYE7315Z4C
1H-Pyrazole-5-carboxamide, 1-methyl-N-[2-methyl-4-[(E)-2-(2-methylphenyl)diazenyl]phenyl]-
1-Methyl-N-{2-methyl-4-[(E)-(2-methylphenyl)diazenyl]phenyl}-1H-pyrazole-5-carboxamide
AhR Antagonist
CH-223191
Chemical & Physical Properties
[ Density]:
1.2±0.1 g/cm3
[ Boiling Point ]:
469.4±45.0 °C at 760 mmHg
[ Molecular Formula ]:
C19H19N5O
[ Molecular Weight ]:
333.387
[ Flash Point ]:
237.7±28.7 °C
[ Exact Mass ]:
333.158966
[ PSA ]:
75.13000
[ LogP ]:
3.48
[ Appearance of Characters ]:
orange-brown
[ Vapour Pressure ]:
0.0±1.2 mmHg at 25°C
[ Index of Refraction ]:
1.633
[ Storage condition ]:
Store at +4°C
[ Water Solubility ]:
DMSO: ≥20mg/mL
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302
[ Hazard Codes ]:
Xn
[ Risk Phrases ]:
22
[ Safety Phrases ]:
22
[ RIDADR ]:
NONH for all modes of transport
Articles
Toxicol. Appl. Pharmacol. 280(3) , 502-10, (2014)
Ahr activation is known to be associated with synovitis and exacerbated rheumatoid arthritis (RA), but its contributions to bone loss have not been completely elucidated. Osteoblast proliferation and ...
J. Pharm. Pharmacol. 67(2) , 170-7, (2015)
It has been reported that intestinal urate excretion is increased at chronic kidney disease (CKD) state. In this report, whether uremic toxins are involved in the upregulation of intestinal breast can...
Toxicol. Sci. 148 , 261-75, (2015)
Cytochrome P450 (CYP) expression and activity are not homogeneous in the liver lobules. Indeed, CYPs are mainly expressed and induced in centrilobular hepatocytes. The wingless-type MMTV integration s...